EUVIMEDEUVIMED entdecken
Crossref

Asymmetric Hydrogenation of Triazolo[1,5- a ]-, Imidazo[1,2- a ]-, and Pyrazolo[1,5- a ]pyridines

Carlo Sambiagio iD, Matthieu D Jouffroy iD, Matthew A Horwitz, José Manuel Bartolomé-Nebreda, Dirk Lauwers, Wouter Herrebout iD, Philip Pye, Kangying Li, Guido Verniest iD, Bert U W Maes iD

Organic Letters · 10.10.2025 · 27 (40) · 11193-11198

DOI: 10.1021/acs.orglett.5c03318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Organic Letters, online erschienen am 26.09.2025. Verfasst von Carlo Sambiagio und 9 weiteren Autor:innen. Beteiligte Einrichtung: Janssen Research & Development, A Division of Janssen Pharmaceutica NV (a Johnson & Johnson Company), Turnhoutseweg 30, 2340 Beerse, Belgium. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Innovative Medicines Initiative, European Commission, European Federation of Pharmaceutical Industries and Associations.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The asymmetric hydrogenation of a series of triazolo[1,5-a]-, imidazo[1,2-a]-, and pyrazolo[1,5-a]pyridines, which have received little coverage in the literature, was investigated. The hydrogenation was achieved in high yields and moderate to good enantioselectivities using Ru precatalysts and bis(naphthylethyl)-substituted NHC ligands (SINpEt). Several new ligands of the SINpEt family were developed, which proved crucial for an enantioselective transformation. Particularly, an alkoxy group at the C2 position of the 1-naphthyl group led to a considerably higher selectivity. Remarkably, hydrogenation at room temperature with H2 pressures as low as 5 bar could be achieved.

Autor:innen und Institutionen

  • Janssen Research & Development, A Division of Janssen Pharmaceutica NV (a Johnson & Johnson Company), Turnhoutseweg 30, 2340 Beerse, Belgium.
  • Organic Synthesis Division, Department of Chemistry, University of Antwerp, Groenenborgerlaan 171, 2020 Antwerp, Belgium.
  • Discovery Chemistry, Janssen-Cilag SL (a Johnson & Johnson Company), C/Jarama 75A, 45007 Toledo, Spain.
  • Theory and Spectroscopy of Molecules and Materials, Department of Chemistry, University of Antwerp, Groenenborgerlaan 171, 2020 Antwerp, Belgium.
  • Janssen Research & Development, LLC (a Johnson & Johnson Company), 920 U.S. Route 202, P.O. Box 300, Raritan, New Jersey 08869, United States.
  • Johnson & Johnson (China) Investment Ltd. Beijing Branch, 14F, Tower 3, China Central Place, No. 77, Jianguo Road, Chaoyang District, Beijing, 100025, P.R. China.

ORCID-Profile: Carlo Sambiagio, Matthieu D Jouffroy, Wouter Herrebout, Guido Verniest, Bert U W Maes

Förderung

  • Innovative Medicines Initiative
  • European Commission
  • European Federation of Pharmaceutical Industries and Associations
  • Antwerp University

Zitieren

APA

Sambiagio, C., Jouffroy, M. D., Horwitz, M. A., Bartolomé-Nebreda, J. M., Lauwers, D., Herrebout, W., Pye, P., Li, K., Verniest, G., & Maes, B. U. W. (2025). Asymmetric Hydrogenation of Triazolo[1,5- a ]-, Imidazo[1,2- a ]-, and Pyrazolo[1,5- a ]pyridines. Organic Letters, 27(40), 11193-11198. https://doi.org/10.1021/acs.orglett.5c03318

Vancouver

Sambiagio C, Jouffroy MD, Horwitz MA, Bartolomé-Nebreda JM, Lauwers D, Herrebout W, et al. Asymmetric Hydrogenation of Triazolo[1,5- a ]-, Imidazo[1,2- a ]-, and Pyrazolo[1,5- a ]pyridines. Organic Letters. 2025;27(40):11193-11198. doi:10.1021/acs.orglett.5c03318

BibTeX
@article{Sambiagio2025,
  author = {Sambiagio, Carlo and Jouffroy, Matthieu D and Horwitz, Matthew A and Bartolomé-Nebreda, José Manuel and Lauwers, Dirk and Herrebout, Wouter and Pye, Philip and Li, Kangying and Verniest, Guido and Maes, Bert U W},
  title = {Asymmetric Hydrogenation of Triazolo[1,5- a ]-, Imidazo[1,2- a ]-, and Pyrazolo[1,5- a ]pyridines},
  journal = {Organic Letters},
  year = {2025},
  volume = {27},
  number = {40},
  pages = {11193--11198},
  doi = {10.1021/acs.orglett.5c03318}
}
Kostenlos starten →